Personal Statement
I am seeking a Member-at-Large position on the SGO Board of Directors because I am deeply committed to advancing our mission of improving the lives of individuals affected by gynecologic cancers through leadership, advocacy, and global collaboration. I have had the privilege to serve SGO in multiple roles, including the International Committee and Clinical Practice Committee and as an SGO Leadership Institute Committee Observer for the Board of Directors, Finance Committee, and Annual Meeting Program Committee. These experiences have strengthened my understanding of the Society’s strategic priorities and deepened my commitment to supporting both our members and our patients. Through the International Committee and as an International Mentor for the IGCS Global Gynecologic Oncology Fellowship Program, I have witnessed the impact of global partnership in advancing education, mentorship, and equitable care. My Clinical Practice Committee service reinforced my passion for developing practical guidelines for high-quality, evidence-based care. As a BRIDGES 2.0 Research Scholar, core member of the NRG Cervix and Vulva Committee, and member of the NCI Gynecologic Cancer Task Force, I am actively engaged in advancing research in gynecologic oncology. Recently, I spoke to my state senator’s office on behalf of SGO about the adverse impact of NIH funding cuts on ongoing and new research and mentorship programs. I shared the importance of SGO and GOG Foundation programs such as BRIDGES for career development and sustained support for a strong pipeline of clinician-scientists. I am dedicated to strengthening mentorship pipelines, promoting global partnerships, and advocating for policies that ensure our continued ability to deliver high-quality, innovative care. I believe these perspectives uniquely position me to contribute meaningfully as a Member-at-Large on the Board of Directors. Together, we can ensure SGO remains the leading voice for gynecologic oncology—driving progress, fostering collaboration, and improving outcomes for patients worldwide.